![Farzaad Abdi-Dezfuli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Farzaad Abdi-Dezfuli
Direttore/Membro del Consiglio presso APIM Therapeutics AS
Profilo
Farzaad Abdi-Dezfuli is currently a Director at APIM Therapeutics AS and a Partner at Sarsia Seed Management AS.
Previously, he worked as a Director at Coegin Pharma.
AS and as a Team Leader at Eli Lilly & Co. and Eli Lilly Norge AS.
He holds a doctorate degree from The University of Edinburgh.
Posizioni attive di Farzaad Abdi-Dezfuli
Società | Posizione | Inizio |
---|---|---|
Sarsia Seed Management AS
![]() Sarsia Seed Management AS Investment ManagersFinance Sarsia Seed Management AS is a venture capital firm headquartered in Bergen, Norway. The company was founded in 2006. | Investitore di Private Equity | 01/09/2006 |
APIM Therapeutics AS
![]() APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Farzaad Abdi-Dezfuli
Società | Posizione | Fine |
---|---|---|
Eli Lilly Norge AS
![]() Eli Lilly Norge AS Medical DistributorsDistribution Services Eli Lilly Norge AS engages in the provision of pharmaceutical products and services. Its commodities were developed for the treatment of diabetes, cardiovascular diseases, cancer, nervous system, osteoporosis, psoriasis, rheumatology, urology, and growth failure. The company was founded in 1976 and is headquartered in Oslo, Norway. | Corporate Officer/Principal | - |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Coegin Pharma AS
![]() Coegin Pharma AS Pharmaceuticals: MajorHealth Technology Coegin Pharma AS provides therapeutics that addresses inflammatory diseases. The company was founded by Berit Johansen on January 3, 2005 and is headquartered in Trondheim, Norway. | Direttore/Membro del Consiglio | - |
Formazione di Farzaad Abdi-Dezfuli
The University of Edinburgh | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
Aziende private | 4 |
---|---|
Sarsia Seed Management AS
![]() Sarsia Seed Management AS Investment ManagersFinance Sarsia Seed Management AS is a venture capital firm headquartered in Bergen, Norway. The company was founded in 2006. | Finance |
Coegin Pharma AS
![]() Coegin Pharma AS Pharmaceuticals: MajorHealth Technology Coegin Pharma AS provides therapeutics that addresses inflammatory diseases. The company was founded by Berit Johansen on January 3, 2005 and is headquartered in Trondheim, Norway. | Health Technology |
Eli Lilly Norge AS
![]() Eli Lilly Norge AS Medical DistributorsDistribution Services Eli Lilly Norge AS engages in the provision of pharmaceutical products and services. Its commodities were developed for the treatment of diabetes, cardiovascular diseases, cancer, nervous system, osteoporosis, psoriasis, rheumatology, urology, and growth failure. The company was founded in 1976 and is headquartered in Oslo, Norway. | Distribution Services |
APIM Therapeutics AS
![]() APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Health Technology |
- Borsa valori
- Insiders
- Farzaad Abdi-Dezfuli